Name: Peking University Institute of Hematology
Diagnosis and treatment of hematological malignancy & hematopoietic stem cell transplantation
Allogeneic HSCT (especially haploidentical transplantation), such as immune tolerance induced by granulocyte colony-stimulating factor, kinetics of immune recovery after haploidentical transplantation, prophylaxis and treatment of relapse, and the mechanisms of poor graft function after transplantation.
Development and function formation of human hematopoietic stem cell in vivo .
Biomarkers for detection of hematological malignancies and effects of these markers on clinical outcomes.
Treatment of acute promyelocytic leukemia with arsenic agents and the underlying mechanisms of which.
Director: Xiaojun Huang
Professor of Medicine and Hematology President, Chinese Society of Hematology, CMA President, Asia Pacific Hematology Consortium, APHCON
No 11 Xizhimen South Street, Beijing 100044, China
Contact: Xiaosu Zhao
Address: Room 804，Experimental Building, Peking University People’s Hospital, No 11 Xizhimen South Street, Beijing 100044, P. R. China.